{
    "clinical_study": {
        "@rank": "60555", 
        "arm_group": [
            {
                "arm_group_label": "heart failure", 
                "arm_group_type": "Other", 
                "description": "aerobic exercise training"
            }, 
            {
                "arm_group_label": "heart failure plus type 2 diabetes", 
                "arm_group_type": "Other", 
                "description": "aerobic exercise training"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to understand the differences in how patients with heart\n      failure respond to exercise training compared to patients with heart failure and type 2\n      diabetes."
        }, 
        "brief_title": "Exercise, Heart Failure, and Type 2 Diabetes", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Heart Failure", 
            "Type 2 Diabetes"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2", 
                "Heart Failure"
            ]
        }, 
        "detailed_description": {
            "textblock": "The investigators will measure exercise capacity in patients with heart failure or heart\n      failure plus type 2 diabetes prior to and following a 12-week exercise training program\n      (5d/wk, 30 min/d, 60-75% VO2max) to determine whether improvements in exercise capacity in\n      response to exercise training are mitigated in patients with combined heart failure plus\n      type 2 diabetes."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  \u226550 yr of age\n\n          -  New York Heart Association class II-III CHF and ejection fraction \u226435%\n\n          -  receiving optimal medical therapy\n\n          -  sedentary (\u2264 30 min/wk structured physical activity).\n\n          -  Half of volunteers (n=30) will have a diagnosis of type 2 diabetes (CHF+T2D).\n\n        Exclusion Criteria:\n\n          -  smoking\n\n          -  changes in medication \u22646 wk prior to enrollment\n\n          -  major cardiovascular event or procedure \u22646 wk prior to enrollment\n\n          -  foot ulcers\n\n          -  advanced neuropathy\n\n          -  co-morbidities or other limitations that may interfere with or prevent volunteers\n             from safely completing the exercise training\n\n          -  fixed rate pacemaker\n\n          -  type 1 diabetes mellitus"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 18, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02122835", 
            "org_study_id": "Pro00032063"
        }, 
        "intervention": {
            "arm_group_label": [
                "heart failure", 
                "heart failure plus type 2 diabetes"
            ], 
            "description": "12 weeks of supervised aerobic exercise training", 
            "intervention_name": "aerobic exercise training", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "exercise", 
            "aerobic exercise"
        ], 
        "lastchanged_date": "April 23, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Durham", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27710"
                }, 
                "name": "Duke University Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Vascular and Metabolic Responses to Exercise Training in Heart Failure With or Without Type 2 Diabetes", 
        "overall_official": {
            "affiliation": "Duke University", 
            "last_name": "William Kraus, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "measured as peak oxygen consumption as well as treadmill time to exhaustion, also known as cardiopulmonary fitness", 
            "measure": "exercise capacity", 
            "safety_issue": "No", 
            "time_frame": "baseline, 12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02122835"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "brachial artery flow-mediated dilation", 
                "measure": "flow-mediated dilation", 
                "safety_issue": "No", 
                "time_frame": "baseline, 12 weeks"
            }, 
            {
                "description": "changes in plasma nitrite during exercise", 
                "measure": "nitrite flux during exercise", 
                "safety_issue": "No", 
                "time_frame": "baseline, 12 weeks"
            }
        ], 
        "source": "Duke University", 
        "sponsors": {
            "collaborator": {
                "agency": "National Heart, Lung, and Blood Institute (NHLBI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Duke University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2012", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}